{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T14:14:58Z","timestamp":1793888098769,"version":"4.8.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81372788"],"award-info":[{"award-number":["81372788"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.cellsig.2018.01.021","type":"journal-article","created":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T12:23:28Z","timestamp":1517401408000},"page":"122-131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["AKT2 contributes to increase ovarian cancer cell migration and invasion through the AKT2-PKM2-STAT3\/NF-\u03baB axis"],"prefix":"10.1016","volume":"45","author":[{"given":"Bin","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaojia","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cellsig.2018.01.021_bb0005","doi-asserted-by":"crossref","first-page":"286","DOI":"10.4331\/wjbc.v5.i3.286","article-title":"In 2014, can we do better than CA125 in the early detection of ovarian cancer?","volume":"5","author":"Cohen","year":"2014","journal-title":"World J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.cellsig.2018.01.021_bb0010","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nrc2664","article-title":"Targeting PI3K signalling in cancer: opportunities, challenges and limitations","volume":"9","author":"Engelman","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cellsig.2018.01.021_bb0015","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jprot.2016.06.009","article-title":"Proteomic analysis of ovarian cancer cells during epithelial-mesenchymal transition (EMT) induced by epidermal growth factor (EGF) reveals mechanisms of cell cycle control","volume":"151","author":"Grassi","year":"2017","journal-title":"J. Proteome"},{"issue":"10","key":"10.1016\/j.cellsig.2018.01.021_bb0020","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.cellsig.2011.05.004","article-title":"AKT signalling in health and disease","volume":"23","author":"Hers","year":"2011","journal-title":"Cell. Signal."},{"issue":"50","key":"10.1016\/j.cellsig.2018.01.021_bb0025","doi-asserted-by":"crossref","first-page":"6473","DOI":"10.1038\/onc.2008.313","article-title":"PI3K\/AKT: getting it right matters","volume":"27","author":"Franke","year":"2008","journal-title":"Oncogene"},{"issue":"1\u20132","key":"10.1016\/j.cellsig.2018.01.021_bb0030","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.canlet.2006.02.018","article-title":"Specific inhibition of AKT2 by RNA interference results in reduction of ovarian cancer cell proliferation: increased expression of AKT in advanced ovarian cancer","volume":"246","author":"Noske","year":"2007","journal-title":"Cancer Lett."},{"issue":"49","key":"10.1016\/j.cellsig.2018.01.021_bb0035","doi-asserted-by":"crossref","first-page":"42211","DOI":"10.1074\/jbc.M111.296905","article-title":"AKT2 kinase suppresses glyceraldehyde-3-phosphate dehydrogenase (GAPDH)-mediated apoptosis in ovarian cancer cells via phosphorylating GAPDH at threonine 237 and decreasing its nuclear translocation","volume":"286","author":"Huang","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.cellsig.2018.01.021_bb0040","first-page":"196","article-title":"Overexpression of AKT2\/protein kinase Bbeta leads to up-regulation of beta1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells","volume":"63","author":"Arboleda","year":"2003","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.cellsig.2018.01.021_bb0045","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1073\/pnas.1014769108","article-title":"Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth","volume":"108","author":"Sun","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.cellsig.2018.01.021_bb0050","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/nrc1478","article-title":"Why do cancers have high aerobic glycolysis?","volume":"4","author":"Gatenby","year":"2004","journal-title":"Nat. Rev. Cancer"},{"issue":"3191","key":"10.1016\/j.cellsig.2018.01.021_bb0055","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.cellsig.2018.01.021_bb0060","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.3892\/ol.2016.4168","article-title":"PKM2 and cancer: the function of PKM2 beyond glycolysis","volume":"11","author":"Dong","year":"2016","journal-title":"Oncol. Lett."},{"issue":"Suppl. 1","key":"10.1016\/j.cellsig.2018.01.021_bb0065","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1079\/BJN2001454","article-title":"Pyruvate kinase type M2: a crossroad in the tumor metabolome","volume":"87","author":"Mazurek","year":"2002","journal-title":"Br. J. Nutr."},{"issue":"31","key":"10.1016\/j.cellsig.2018.01.021_bb0070","doi-asserted-by":"crossref","first-page":"31958","DOI":"10.18632\/oncotarget.5579","article-title":"miR675 upregulates long noncoding RNA H19 through activating EGR1 in human liver cancer","volume":"6","author":"Li","year":"2015","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.cellsig.2018.01.021_bb0075","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/pros.23261","article-title":"Glyoxalase 2 is involved in human prostate cancer progression as part of a mechanism driven by PTEN\/PI3K\/AKT\/mTOR signaling with involvement of PKM2 and ERalpha","volume":"77","author":"Talesa","year":"2017","journal-title":"Prostate"},{"issue":"11","key":"10.1016\/j.cellsig.2018.01.021_bb0080","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s00432-008-0398-y","article-title":"Identification of transgelin as a potential novel biomarker for gastric adenocarcinoma based on proteomics technology","volume":"134","author":"Huang","year":"2008","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.cellsig.2018.01.021_bb0085","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1476-4598-11-79","article-title":"Epidermal growth factor (EGF) and interleukin (IL)-1beta synergistically promote ERK1\/2-mediated invasive breast ductal cancer cell migration and invasion","volume":"11","author":"Ma","year":"2012","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cellsig.2018.01.021_bb0090","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1186\/1471-2407-10-437","article-title":"Correlation of NF-kappaB signal pathway with tumor metastasis of human head and neck squamous cell carcinoma","volume":"10","author":"Yan","year":"2010","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.cellsig.2018.01.021_bb0095","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.trecan.2017.04.002","article-title":"Targeting PI3K signaling in combination cancer therapy","volume":"3","author":"Pons-Tostivint","year":"2017","journal-title":"Trends in Cancer"},{"issue":"9","key":"10.1016\/j.cellsig.2018.01.021_bb0100","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1158\/1078-0432.CCR-14-0854","article-title":"Molecular pathways: targeting NRG1 fusions in lung cancer","volume":"21","author":"Fernandez-Cuesta","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.cellsig.2018.01.021_bb0105","doi-asserted-by":"crossref","first-page":"232","DOI":"10.7555\/JBR.31.20160039","article-title":"Ginkgol C17:1 inhibits tumor growth by blunting the EGF-PI3K\/AKT signaling pathway","volume":"31","author":"Li","year":"2017","journal-title":"Journal of Biomedical Research"},{"issue":"5","key":"10.1016\/j.cellsig.2018.01.021_bb0110","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.cell.2014.08.003","article-title":"PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis","volume":"158","author":"Yang","year":"2014","journal-title":"Cell"},{"issue":"7375","key":"10.1016\/j.cellsig.2018.01.021_bb0115","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature10598","article-title":"Nuclear PKM2 regulates beta-catenin transactivation upon EGFR activation","volume":"480","author":"Yang","year":"2011","journal-title":"Nature"},{"issue":"38","key":"10.1016\/j.cellsig.2018.01.021_bb0120","doi-asserted-by":"crossref","first-page":"40959","DOI":"10.18632\/oncotarget.5726","article-title":"PTTG regulates the metabolic switch of ovarian cancer cells via the c-myc pathway","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"issue":"20","key":"10.1016\/j.cellsig.2018.01.021_bb0125","doi-asserted-by":"crossref","first-page":"33047","DOI":"10.18632\/oncotarget.16523","article-title":"iNOS-derived nitric oxide promotes glycolysis by inducing pyruvate kinase M2 nuclear translocation in ovarian cancer","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"issue":"22","key":"10.1016\/j.cellsig.2018.01.021_bb0130","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1038\/onc.2016.460","article-title":"Role of AKT2 in regulation of metastasis suppressor 1 expression and colorectal cancer metastasis","volume":"36","author":"Agarwal","year":"2017","journal-title":"Oncogene"},{"issue":"46","key":"10.1016\/j.cellsig.2018.01.021_bb0135","doi-asserted-by":"crossref","first-page":"74820","DOI":"10.18632\/oncotarget.11204","article-title":"AKT isoform specific effects in ovarian cancer progression","volume":"7","author":"Linnerth-Petrik","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.cellsig.2018.01.021_bb0140","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.canlet.2014.01.031","article-title":"PKM2 contributes to cancer metabolism","volume":"356","author":"Wong","year":"2015","journal-title":"Cancer Lett."},{"issue":"7","key":"10.1016\/j.cellsig.2018.01.021_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182166","article-title":"Pyruvate kinase M2 is a poor prognostic marker of and a therapeutic target in ovarian cancer","volume":"12","author":"Chao","year":"2017","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.cellsig.2018.01.021_bb0150","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.4155\/fmc.14.70","article-title":"Activators of PKM2 in cancer metabolism","volume":"6","author":"Warner","year":"2014","journal-title":"Future Med. Chem."},{"issue":"6","key":"10.1016\/j.cellsig.2018.01.021_bb0155","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3727\/096504016X14685034103671","article-title":"Inhibition of proliferation, migration, and invasion by knockdown of pyruvate kinase-M2 (PKM2) in ovarian cancer SKOV3 and OVCAR3 cells","volume":"24","author":"Miao","year":"2016","journal-title":"Oncol. Res."},{"issue":"4","key":"10.1016\/j.cellsig.2018.01.021_bb0160","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1042\/BST20130034","article-title":"Role of PI3K, mTOR and AKT2 signalling in hepatic tumorigenesis via the control of PKM2 expression","volume":"41","author":"Nemazanyy","year":"2013","journal-title":"Biochem. Soc. Trans."},{"issue":"38","key":"10.1016\/j.cellsig.2018.01.021_bb0165","doi-asserted-by":"crossref","first-page":"40799","DOI":"10.18632\/oncotarget.5695","article-title":"MicroRNA-29B (mir-29b) regulates the Warburg effect in ovarian cancer by targeting AKT2 and AKT3","volume":"6","author":"Teng","year":"2015","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.cellsig.2018.01.021_bb0170","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/ijc.30817","article-title":"uPA\/uPAR system activation drives a glycolytic phenotype in melanoma cells","volume":"141","author":"Laurenzana","year":"2017","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.cellsig.2018.01.021_bb0175","doi-asserted-by":"crossref","first-page":"778","DOI":"10.4143\/crt.2015.485","article-title":"Effects and mechanisms of metformin on the proliferation of esophageal cancer cells in vitro and in vivo","volume":"49","author":"Tang","year":"2017","journal-title":"Cancer Res. Treat."},{"issue":"30","key":"10.1016\/j.cellsig.2018.01.021_bb0180","doi-asserted-by":"crossref","first-page":"48155","DOI":"10.18632\/oncotarget.10179","article-title":"AKT-induced PKM2 phosphorylation signals for IGF-1-stimulated cancer cell growth","volume":"7","author":"Park","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.cellsig.2018.01.021_bb0185","article-title":"Pyruvate kinase M2 activates mTORC1 by phosphorylating AKT1S1","volume":"6","author":"He","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.cellsig.2018.01.021_bb0190","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1038\/s41598-017-03031-1","article-title":"PKM2 promotes cell migration and inhibits autophagy by mediating PI3K\/AKT activation and contributes to the malignant development of gastric cancer","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656818300275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656818300275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T15:56:45Z","timestamp":1693497405000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656818300275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":38,"alternative-id":["S0898656818300275"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2018.01.021","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AKT2 contributes to increase ovarian cancer cell migration and invasion through the AKT2-PKM2-STAT3\/NF-\u03baB axis","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2018.01.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}